Diabetes Treatment and Management
Open access
Peer reviewed
Scollr summary
What this paper is about
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to a composite of death from cardiovascular causes, myocardial infarction, or stroke.
Full abstract
Read the full abstract
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to a composite of death from cardiovascular causes, myocardial infarction, or stroke. (Funded by Eli Lilly; SURPASS-CVOT ClinicalTrials.gov number, NCT04255433.).
Direct answer
What can I do from this paper page?
Use this page to scan "Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Diabetes Treatment and Management research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Nicholls2025Cardiovascular,
title = {Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes},
author = {Stephen J. Nicholls and Imre Pávó and Deepak L. Bhatt and John B. Buse and Stefano Del Prato and Steven E. Kahn and A. Michael Lincoff and Darren K. McGuire and Debra L. Miller and Michael A. Nauck and Hiroshi Nishiyama and Steven E. Nissen and Naveed Sattar and Govinda Weerakkody and Russell J. Wiese and Bernard Zinman and Sophia Zoungas and Jan Basile and Melanie J Davies and Francesco Giorgino and Monika Kellerer and Linong Ji and Tamás Várkonyi and Venu Menon and Jonathan Broder and Alan Herschtal and David A. D’Alessio},
journal = {New England Journal of Medicine},
year = {2025},
doi = {10.1056/nejmoa2505928},
url = {https://doi.org/10.1056/nejmoa2505928}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Diabetes Treatment and Management research papers?
Follow Diabetes Treatment and Management research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app